IL-33 is a mediator of allergic inflammation and is localized in mucosal tissues to respond rapidly to environmental insults. These include allergens themselves, which can directly activate IL-33 through their intrinsic proteolytic activity.
References
Lefrançais, E. et al. Proc. Natl Acad. Sci. USA 109, 1673–1678 (2012).
Lefrançais, E. et al. Proc. Natl Acad. Sci. USA 111, 15502–15507 (2014).
Cayrol, C. et al. Nat. Immunol. https://doi.org/10.1038/s41590-018-0067-5 (2018).
Scott, I.C. et al. Sci. Rep. 8, 3363 (2018).
Lüthi, A. U. et al. Immunity 31, 84–98 (2009).
Snelgrove, R. J. et al. J. Allergy Clin. Immunol. 134, 583–592 (2014).
Hong, J. et al. J. Biol. Chem. 286, 20078–20086 (2011).
Sokol, C. L., Barton, G. M., Farr, A. G. & Medzhitov, R. Nat. Immunol. 9, 310–318 (2008).
de Kleer, I. M. et al. Immunity 45, 1285–1298 (2016).
Palm, N. W. et al. Immunity 39, 976–985 (2013).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
Smith, D.E. IL-33 meets allergens at the gate. Nat Immunol 19, 318–320 (2018). https://doi.org/10.1038/s41590-018-0069-3
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41590-018-0069-3
- Springer Nature America, Inc.
This article is cited by
-
Biologics in Treatment for Chronic Rhinosinusitis with Comorbid Asthma
Current Treatment Options in Allergy (2021)